文献速递肿瘤 PET/CT

在标准延迟PET方案中加入早期动态采集可增强18F-FDG PET/CT在膀胱癌中的应用

Enhanced Application of 18F-FDG PET/CT in Bladder Cancer by Adding Early Dynamic Acquisition to a Standard Delayed PET Protocol.
PubMed 文献 · Clin Nucl Med · 2017-01-01

该研究前瞻性纳入52例膀胱癌患者,比较早期动态(ED)、全身(WB,注射后60分钟)和额外延迟(AD,注射后120分钟)PET对膀胱癌的检出与表征价值。ED PET灵敏度为84.6%,显著高于WB的57.7%(P=0.002)和AD的61.2%(P=0.008)。ED PET的SUVmax与肌层浸润、组织学分级和病理肿瘤大小显著相关,而WB和AD PET仅肿瘤大小与SUVmax显著正相关。

要点

  • ED PET检出膀胱癌灵敏度84.6%,显著高于WB的57.7%(P=0.002)和AD的61.2%(P=0.008)。
  • ED PET的SUVmax与肌层浸润(P=0.018)、组织学分级(P=0.030)和病理肿瘤大小(P=0.030)显著相关。
  • WB和AD PET仅病理肿瘤大小与SUVmax显著正相关(P=0.043和P=0.007)。

核心结论

  • 早期动态PET有助于膀胱癌的检出和表征。

研究设计与样本

  • 前瞻性纳入52例膀胱癌患者,研究方案包括早期动态(ED)、全身(WB,注射后60分钟)和额外延迟(AD,注射后120分钟)PET采集。
  • ED PET采集10分钟,按2分钟间隔重建为5帧;膀胱壁局灶性放射性示踪剂积聚视为PET阳性并进一步定量测量。
  • 测量ED各帧SUVmax(5帧)、WB的SUVmax和AD PET的SUVmax,并将PET结果与膀胱癌病理变量进行相关性分析。

主要发现

  • ED、WB和AD PET对膀胱癌的灵敏度分别为84.6%、57.7%和61.2%。
  • ED PET灵敏度显著高于WB(P=0.002)和AD PET(P=0.008)。
  • ED PET的SUVmax与肌层浸润(P=0.018)、组织学分级(P=0.030)和病理肿瘤大小(P=0.030)显著相关。
  • WB和AD PET仅病理肿瘤大小与SUVmax呈显著正相关(P=0.043和P=0.007)。

关键数值与推荐

  • 膀胱壁局灶性放射性示踪剂积聚视为PET阳性并转进一步定量测量。
  • ED PET灵敏度84.6%,WB PET灵敏度57.7%,AD PET灵敏度61.2%。
  • ED PET的SUVmax与肌层浸润P=0.018、组织学分级P=0.030、病理肿瘤大小P=0.030显著相关。
  • WB和AD PET的SUVmax与病理肿瘤大小显著正相关(P=0.043和P=0.007)。

临床怎么用

  • 原文未据此给出临床推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

PURPOSE: We investigated the value of early dynamic (ED) PET for the detection and characterization of bladder cancer. METHODS: Fifty-two bladder cancer patients were prospectively enrolled. The study protocol was composed of ED, whole-body (WB, 60 minutes after injection), and additional delayed (AD, 120 minutes after injection) PET acquisition. Early dynamic PET was acquired for 10 minutes and reconstructed as 5 frames at 2-minute intervals. A focal radiotracer accumulation confined to the bladder wall was considered as PET positive and referred for further quantitative measurement. SUVmax on ED (SUVmax, SUVmax, SUVmax, SUVmax, and SUVmax for 5 frames), WB (SUVmax), and AD PET (SUVmax) were measured. PET results were correlated with bladder cancer pathology variables. RESULTS: The sensitivities of ED, WB, and AD PET for bladder cancer were 84.6%, 57.7%, and 61.2%, respectively. The sensitivity of ED PET was significantly higher than that of WB (P = 0.002) and AD PET (P = 0.008). On ED PET, SUVmax was significantly correlated with muscle invasiveness, histological grade, and pathological tumor size (P = 0.018, P = 0.030, and P = 0.030). On WB and AD PET, only pathological tumor size showed significant positive correlation with SUVmax and SUVmax (P = 0.043 and P = 0.007). CONCLUSIONS: Early dynamic PET can help to detect and characterize bladder cancer.

来源:Clin Nucl Med,查看原文。版权归原作者所有。

引用

  1. Yoon HJ, Yoo J, Kim Y, et al. Enhanced Application of 18F-FDG PET/CT in Bladder Cancer by Adding Early Dynamic Acquisition to a Standard Delayed PET Protocol. Clin Nucl Med. 2017. PMID: 28759520. doi:10.1097/RLU.0000000000001780

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。